Some say “Isn’t it enough to be a biologist to understand aging and disease? Why bring in physics?”. As a physicist working on the biology of aging, I understand the skepticism. After all, chemistry is ultimately physics, yet chemists get by without deeply knowing quantum

RT @GeroMaxim: WHY THIS LONGEVITY MULTI-BILLION DEAL MATTERS — AND WHAT COMES NEXT. It’s only natural that a deal like this sparks a wave o….

Level 1: Tackling individual hallmarks of aging, like metabolic health or inflammation (adding years to life). Level 2: Stabilizing biological systems against random fluctuations—reducing physiological “noise” that destabilizes health as we age (adding decades of healthy life).

BREAKING: Gero Signs Potential Multi-Billion-$  Deal to Fuel Our Mission to Stop Aging  --. A few years ago, my son, aged five at the time, asked what happened to the dinosaurs. After learning their sad story, he told me he wanted to fly to the Moon and defend Earth from falling

thank you @LongevityTech for covering.

the link to the publication 2/2.

In my last post, I discussed how we think of biologics such as antibodies or gene therapies against aging. But what if we could instead vaccinate against aging?. This may sound audacious and even dangerous, but the concept is grounded in solid immunology. Imagine a host

here's 2020 molecule of the year review at Drug Hunter 2/2.

For decades, scientists and entrepreneurs have debated what the perfect anti-aging drug should look like. Since aging is chronic and systemic, people naturally think of long-lasting therapies like vaccines, monoclonal antibodies, or gene therapies. The dream is a one-time

For my friends who care : there are two nova stars in the sky (search nova star 2025 to assess your options).

RT @BiotechTV: 𝐀𝐈 𝐍𝐞𝐰𝐬: Singapore based @hacking_aging, a ompany focused on small molecules for aging conditions, launched ProtoBind-Diff,….

Subscribe for notification of future updates, including code and public demo at

here's the link to the preprint 2/2.

Designing small molecules to hit protein targets is the holy grail of drug discovery, but it’s a beast of a problem. For years, I’ve been obsessed with finding a practical way to crack it. Coming from a physics background, my gut always leaned toward modeling—think docking +

Excited to share that I will be joining @athena_dao_’s Demo Day on Wednesday, June 25th, at 9:00 AM PT / 12:00 PM ET / 6:00 PM CET. I’ll be talking about my work . APPLY TO ATTEND 👇

RT @MaxUnfried: The Physics of Aging - Gerophysics - is gaining wider interest amongst the aging biology community. But where should artic….

RT @DcodLongevity: 🎙️ New episode alert!. We’re back with Part 2 of our deep-dive with Peter Fedichev (@fedichev ), co-founder of @hacking_….

Back in the day, 'playing with models' meant plastic airplanes. Then it meant dating runway girls. Now it means debugging neural nets till 3am.

Over the past 10 days, I’ve had the chance to chat with some fascinating people, and the conversation kept circling back to AI. Here are some intriguing observations:. * AI and Longevity Investments. AI advises investors to bet on anti-aging biotech. If you’ve got $20 million or